Notify me when BENJAMIN J. ZESKIND files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IMRX | Immuneering Corporation | Class A common stock, par value $0.001 per share | 6.6% | $28,674,370 | +$2,498,025 | 4,357,807 | +9.5% | BENJAMIN J. ZESKIND | 31 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|